The JAK/STAT pathway is involved in the maintenance, proliferation, and immune evasion of CSCs, and dysregulated JAK/STAT signaling in CSCs can promote tumor growth and resistance to therapy [61, 203–206]. The gene discussed is SOAT1; the disease is neoplasm.